TC
EXAS

Truvestments Capital’s Exact Sciences EXAS Stock Holding History

Truvestments Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-58
Closed -$5.89K – 1191
2025
Q4 		$5.89K Hold
58
– – ﹤0.01% 774
2025
Q3 		$3.17K Hold
58
– – ﹤0.01% 883
2025
Q2 		$3.08K Hold
58
– – ﹤0.01% 791
2025
Q1 		$2.51K Hold
58
– – ﹤0.01% 836
2024
Q4 		$3.26K Hold
58
– – ﹤0.01% 760
2024
Q3 		$3.95K Buy
+58
New +$3.27K ﹤0.01% 714
2024
Q2 		– Sell
-91
Closed -$6.28K – 385
2024
Q1 		$6.28K Hold
91
– – ﹤0.01% 535
2023
Q4 		$6.73K Hold
91
– – ﹤0.01% 558
2023
Q3 		$6.21K Hold
91
– – ﹤0.01% 491
2023
Q2 		$8.54K Hold
91
– – ﹤0.01% 466
2023
Q1 		$6.17K Buy
+91
New +$5.85K ﹤0.01% 487
2018
Q3 		$63K Buy
+800
New +$52.2K 0.03% 339

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Truvestments Capital's EXAS Position: Q1 2026 in Review

Truvestments Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 58 shares — an estimated $5.89K sold.

Truvestments Capital first reported a position in EXAS in Q3 2018 and held it in 12 quarters. The position peaked at $63K in Q3 2018. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Truvestments Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Truvestments Capital sold 58 Exact Sciences shares in Q1 2026, an estimated $5.89K.
  • Truvestments Capital first reported a position in Exact Sciences in Q3 2018 and held it in 12 quarters.
  • Truvestments Capital's Exact Sciences position peaked at $63K in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.